Order results by:
| Issue | Title | |
| Vol 16, No 2 (2020) | Patients with Premature Cardiovascular Diseases in Ambulatory Practice: Demographic Characteristics, Risk Factors and Adherence to the Medical Therapy (Data of RECVASA Registry) | Abstract similar documents |
| E. Yu. Andreenkо, M. M. Loukianov, S. S. Yakushin, A. N. Vorobyev, K. G. Pereverzeva, V. A. Dindikova, A. N. Makoveeva, E. V. Kudryashov, S. A. Boytsov, O. M. Drapkina | ||
| "... of Russia. Groups of patients with early development of CVD (criterion 1 – the age of 18-49 years old ..." | ||
| Vol 18, No 5 (2022) | Clinical and Anamnestic Characteristics, Cardiovascular Pharmacotherapy and Long-term Outcomes in Multimorbid Patients after COVID-19 | Abstract similar documents |
| A. A. Smirnov, M. M. Loukianov, S. Yu. Martsevich, A. A. Pulin, N. P. Kutishenko, E. Yu. Andreenko, V. P. Voronina, V. A. Dindikova, N. A. Dmitrieva, M. M. Kudryavtseva, O. V. Lerman, A. N. Makoveeva, E. Yu. Okshina, A. A. Maltseva, E. N. Belova, V. G. Klyashtorniy, E. V. Kudryashov, O. E. Karpov, O. M. Drapkina | ||
| "... included in the TARGET-VIP registry, the CVMM criterion was the presence of two or more CVDs: arterial ..." | ||
| Vol 19, No 2 (2023) | Statins and highly sensitive cardiac troponins: cardiotoxicity or cross-reactivity? | Abstract similar documents |
| A. M. Chaulin, D. V. Duplyakov | ||
| "... diseases (CVD). Therefore, considerable attention of researchers is focused on statins to study ..." | ||
| Vol 15, No 6 (2019) | Association of Family History of Cardiovascular Diseases in Boys Aged 12-13 Years with Structural and Functional Indicators of the Left Ventricle and Arterial Stiffness in the Age of 43-46 Years (Results of 32-Year Prospective Follow-up) | Abstract similar documents |
| O. Yu. Isaykina, V. B. Rozanov, A. A. Aleksandrov, I. V. Leontyeva, M. B. Kotova, E. I. Ivanova | ||
| "... Aim. To evaluate the association of Family History (FH) of cardiovascular diseases (CVD) in boys ..." | ||
| Vol 14, No 6 (2018) | Availability and Affordability of Medicines for the Treatment of Cardiovascular Diseases in Pharmacies in Six Regions of the Russian Federation | Abstract PDF (Eng) similar documents |
| A. E. Imaeva, Yu. A. Balanova, A. V. Kontsevaya, A. V. Kapustina, D. V. Duplyakov, O. H. Malysheva, I. V. Osipova, T. A. Petrichko, G. I. Kropanin, R. A. Kasimov, D. A. Leon, M. McKee | ||
| "... diseases (CVD) in several regions of the Russian Federation with different climatic, geographic, economic ..." | ||
| Vol 15, No 1 (2019) | Factors Associated with Cause-Specific Death in Russia. Data from Longitudinal Prospective Study 1977-2001 | Abstract PDF (Eng) similar documents |
| S. A. Shalnova, A. V. Kapustina, A. D. Deev, Yu. A. Balanova | ||
| "... (CVD), non-CVD, all causes. A total of 10,650 deaths were registered: 8,726 in men (for 10 years) and 1 ..." | ||
| Vol 13, No 4 (2017) | PATIENTS WITH ATRIAL FIBRILLATION IN MULTIDISCIPLINARY HOSPITAL: STRUCTURE OF HOSPITALIZATION, CONCOMITANT CARDIOVASCULAR DISEASES AND DRUG TREATMENT (DATA OF RECVASA AF-TULA REGISTRY) | Abstract similar documents |
| M. N. Valiakhmetov, T. A. Gomova, M. M. Loukianov, S. Yu. Martsevich, K. N. Nadejkina, M. N. Artemova, D. N. Jilin, E. E. Fedotova, A. V. Zagrebelnyy, E. V. Kudryashov, S. A. Boytsov | ||
| "... cardiovascular diseases (CVD) and drug therapy within the RECVAZA AF-Tula hospital registry. Material ..." | ||
| Vol 8, No 4 (2012) | UP TO DATE STATINS IN PRIMARY AND SECONDARY PREVENTION OF CARDIOVASCULAR DISEASES | Abstract similar documents |
| N. F. Puchin'yan, Ya. P. Dovgalevskiy, A. V. Panina | ||
| "... components according to multifactor origin of cardiovascular disease (CVD). Correction of lipid metabolism ..." | ||
| Vol 20, No 6 (2024) | Medical treatment of cardiovascular diseases in patients after hospitalization for COVID-19 (three-year follow-up data in the TARGET-VIP registry) | Abstract similar documents |
| N. P. Kutishenko, S. Yu. Martsevich, M. M. Loukianov, E. Yu. Andreenko, V. P. Voronina, V. A. Dindikova, N. A. Dmitrieva, M. M. Kudryavtseva, O. V. Lerman, E. Yu. Okshina, A. A. Smirnov, A. G. Soplenkova, A. A. Pulin, N. N. Kuzina, D. A. Nefedova, V. G. Klyashtorniy, O. E. Karpov, O. M. Drapkina | ||
| "... Aim. To evaluate the quality of drug treatment of patients with cardiovascular diseases (CVD ..." | ||
| Vol 15, No 5 (2019) | Patients with History of Myocardial Infarction and Acute Cerebrovascular Accidentin Clinical Practice: Demographic, Clinical Characteristics, Drug Treatment and Outcomes (Data of Outpatient and Hospital Registry REGION) | Abstract similar documents |
| E. Yu. Okshina, M. M. Loukianov, S. Yu. Martsevich, S. S. Yakushin, N. P. Kutishenko, A. N. Vorobyev, K. G. Pereverzeva, A. V. Zagrebelnyy, V. P. Voronina, N. A. Dmitrieva, O. V. Lerman, E. V. Kudryashov, S. A. Boytsov, O. M. Drapkina | ||
| "... ”). The incidence of cardiovascular diseases (CVD), non-CVD comorbidities, drug therapy and outcomes were analyzed ..." | ||
| Vol 15, No 2 (2019) | Detectability of Subclinical Hypothyroidism and Thyroid Stimulating Hormone Levels Associated with Cardiovascular Diseases in Patients of North-West Region Hospital | Abstract similar documents |
| A. R. Volkova, O. D. Dygun, O. N. Zhdanova, B. G. Lukichev, L. A. Belyakova, E. M. Sereda | ||
| "... with cardiovascular diseases (CVD) is an important clinical task. Aim. To study the detectability of subclinical ..." | ||
| Vol 12, No 4 (2016) | Continuum of non-alcoholic fatty liver disease: from hepatic steatosis to cardiovascular risk | Abstract similar documents |
| O. M. Drapkina, O. N. Korneeva | ||
| "... for a number of cardiovascular diseases (CVD), is considered. The high prevalence of cardiovascular risk ..." | ||
| Vol 17, No 6 (2021) | Patients with a Combination of Atrial Fibrillation and Chronic Heart Failure in Clinical Practice: Comorbidities, Drug Treatment and Outcomes | Abstract PDF (Eng) similar documents |
| M. M. Loukianov, S. Yu. Martsevich, Yu. V. Mareev, S. S. Yakushin, E. Yu. Andreenko, A. N. Vorobiev, K. G. Pereverzeva, A. V. Zagrebelny, E. Yu. Okshina, V. V. Yakusevich, Vl. Vl. Yakusevich, E. M. Pozdnyakova, T. A. Gomova, E. E. Fedotova, M. N. Valiakhmetov, V. P. Mikhin, Yu. V. Maslennikova, E. N. Belova, V. G. Klyashtorny, E. V. Kudryashov, A. N. Makoveeva, Yu. E. Tatsiy, S. A. Boytsov, O. M. Drapkina | ||
| "... (CHF) based on prospective registries of patients with cardiovascular diseases (CVD). Materials ..." | ||
| Vol 5, No 1 (2009) | CARDIOLOGICAL MANAGEMENT OF PREGNANT WOMEN IN THE UDMURT REPUBLIC | Abstract similar documents |
| I. R. Gaisin, R. M. Valeeva, L. V. Shilina, N. Yu. Chernisheva, N. I. Maksimov | ||
| "... diseases (CVD) in the Udmurt Republic (UR) of Russia. Material and methods. In prospective ..." | ||
| Vol 12, No 2 (2016) | CORRELATIONS OF DIFFERENT STRUCTURAL AND FUNCTIONAL CHARACTERISTICS OF ARTERIAL WALL WITH TRADITIONAL CARDIOVASCULAR RISK FACTORS IN HEALTHY PEOPLE OF DIFFERENT AGE. PART 1 | Abstract PDF (Eng) PDF (Eng) similar documents |
| I. D. Strazhesko, O. N. Tkacheva, D. U. Akasheva, E. V. Dudinskaya, M. V. Agaltsov, A. S. Kruglikova, N. V. Brailova, V. S. Pykhtina, E. V. Plokhova, N. V. Sharashkina, O. Yu. Isaykina, V. A. Vygodin, S. A. Boytsov | ||
| "... for cardiovascular disease (CVD) grows. The nature of relationship between these indices in people without CVD ..." | ||
| Vol 12, No 3 (2016) | REPORT ON THE ROUND-TABLE MEETING: "REGISTERS IN CARDIOLOGY: THE BASIC RULES OF MANAGEMENT, MODERN EXPERIENCE AND THE RESULTS OF THEIR CREATION IN THE VARIOUS REGIONS OF THE RUSSIAN FEDERATION" | Abstract PDF (Eng) similar documents |
| S. Yu. Martsevich, M. M. Loukianov, N. P. Kutishenko | ||
| "... of various cardiovascular diseases (CVD) were among participants of the meeting. The importance of modern ..." | ||
| Vol 10, No 5 (2014) | OUTPATIENT REGISTRY OF CARDIOVASCULAR DISEASES (RECVASA): PROSPECTIVE FOLLOW-UP DATA, ESTIMATION OF RISKS AND OUTCOMES IN PATIENTS WITH ATRIAL FIBRILLATION | Abstract PDF (Eng) similar documents |
| M. M. Loukianov, S. A. Boytsov, S. S. Yakushin, S. Yu. Martsevich, A. N. Vorobyev, A. V. Zagrebelnyy, M. S. Kharlap, K. G. Pereverzeva, E. A. Pravkina, S. E. Serdyuk, A. D. Deev, E. N. Kudryashov | ||
| "... cardiovascular surgery. There were 63 hospitalizations due to cardiovascular diseases (CVD). AF did not lead ..." | ||
| Vol 12, No 3 (2016) | CORRELATIONS OF DIFFERENT STRUCTURAL AND FUNCTIONAL CHARACTERISTICS OF ARTERIAL WALL WITH TRADITIONAL CARDIOVASCULAR RISK FACTORS IN HEALTHY PEOPLE OF DIFFERENT AGE. PART 2 | Abstract PDF (Eng) similar documents |
| I. D. Strazhesko, O. N. Tkacheva, D. U. Akasheva, E. V. Dudinskaya, M. V. Agaltsov, A. S. Kruglikova, N. V. Brailova, V. S. Pykhtina, E. V. Plokhova, N. V. Sharashkina, O. Yu. Isaykina, V. A. Vygodin, S. A. Boytsov | ||
| "... of effective cardiovascular disease (CVD) primary prevention. Such lesions include: arterial wall thickening ..." | ||
| Vol 14, No 2 (2018) | ECONOMIC BURDEN OF CARDIOVASCULAR DISEASES IN THE RUSSIAN FEDERATION IN 2016 | Abstract PDF (Eng) similar documents |
| A. N. Kontsevaya, O. M. Drapkina, Yu. A. Balanova, A. E. Imaeva, E. I. Suvorova, M. B. Khudyakov | ||
| "... Aim. To evaluate the economic burden of cardiovascular diseases (CVD) in the Russian Federation ..." | ||
| Vol 16, No 1 (2020) | Patients with Combination of Cardiovascular Diseases and Type 2 Diabetes in RECVASA and REGION Registries: Multimorbidity, Outcomes and Potential Effect of Dapagliflozin in the Russian Clinical Practice | Abstract similar documents |
| M. M. Loukianov, A. V. Kontsevaya, A. O. Myrzamatova, M. B. Khudyakov, E. Y. Okshina, E. V. Kudryashov | ||
| "... of dapagliflozin in patients with a combination of cardiovascular disease (CVD) and type 2 diabetes in Russian ..." | ||
| Vol 11, No 5 (2015) | The role of peptide hormones (adiponectin, leptin, insulin) in the pathogenesis of atherosclerosis | Abstract similar documents |
| S. A. Smetnev, A. N. Meshkov | ||
| "... Currently, cardiovascular diseases (CVD) remain the main problem in the world and in Russia ..." | ||
| Vol 16, No 2 (2020) | Gut Microbiota Composition and Metabolites as the new Determinants of Cardiovascular Pathology Development | Abstract similar documents |
| O. M. Drapkina, A. N. Kaburova | ||
| "... . In this group cardiovascular diseases (CVD) are known to be the leading cause of death which pathogenesis still ..." | ||
| Vol 18, No 2 (2022) | Hostility, Anger, Psycho-emotional Factors and Cardiovascular Disease | Abstract similar documents |
| G. F. Andreeva, V. M. Gorbunov | ||
| "... centuries. In the second part, the authors demonstrated that hostility/anger are a risk factor for the CVD ..." | ||
| Vol 16, No 5 (2020) | Associations of Blood Pressure and Heart Rate and Their Contribution to the Development of Cardiovascular Complications and All-Cause Mortality in the Russian Population of 25-64 Years | Abstract similar documents |
| S. A. Shalnova, V. A. Kutsenko, A. V. Kapustina, E. B. Yarovaya, Yu. A. Balanova, S. E. Evstifeeva, A. E. Imaeva, S. A. Maksimov, G. A. Muromtseva, N. V. Kulakova, O. N. Kalachikova, T. M. Chernykh, O. A. Belova, G. V. Artamonova, E. V. Indukaeva, Yu. I. Grinshtein, R. A. Libis, D. V. Duplyakov, O. P. Rotar, I. A. Trubacheva, V. N. Serebryakova, A. Yu. Efanov, A. O. Konradi, S. A. Boytsov, O. M. Drapkina | ||
| "... cardiovascular diseases (CVD) and mortality from all causes. Material and methods. Prospective observation ..." | ||
| Vol 11, No 5 (2015) | Excess winter cardiovascular morbidity in Ivanovo Region in 2009-2013 years | Abstract similar documents |
| A. V. Kontsevaya, J. A. Balanova, M. M. Loukianov, M. B. Khudyakov, O. A. Belova, S. V. Romanchuk | ||
| "... . The incidence of cardiovascular diseases (CVDs) was determined according to the data from the medical ..." | ||
| Vol 16, No 6 (2020) | Patients with Atrial Fibrillation in Clinical Practice: Comorbidity, Drug Treatment and Outcomes (Data from RECVASA Registries) | Abstract similar documents |
| M. M. Loukianov, E. Yu. Andreenko, S. Yu. Martsevich, S. S. Yakushin, A. N. Vorobyev, K. G. Pereverzeva, A. V. Zagrebelnyy, E. Yu. Okshina, V. V. Yakusevich, V. Vl. Yakusevich, E. M. Pozdnyakova, T. A. Gomova, E. E. Fedotova, M. N. Valiakhmetov, V. P. Mikhin, Yu. V. Maslennikova, V. G. Klyashtorny, E. V. Kudryashov, Ju. E. Tatsii, S. A. Boytsov, O. M. Drapkina | ||
| "... with combination of 3-4 cardiovascular diseases (CVD), including AF (98.0% vs 81.7%, p<0.0001), and also ..." | ||
| Vol 12, No 1 (2016) | CONCOMITANT CARDIOVASCULAR DISEASES AND ANTIHYPERTENSIVE TREATMENT IN OUTPATIENT PRACTICE (BY THE RECVASA REGISTRY DATA) | Abstract PDF (Eng) similar documents |
| M. M. Loukianov, S. A. Boytsov, S. S. Yakushin, S. Yu. Martsevich, A. N. Vorobyev, A. V. Zagrebelnyy, N. N. Nikulina, K. G. Pereverzeva, E. A. Pravkina, A. D. Deev, E. V. Kudryashov, E. N. Belova | ||
| "... Aim. To study a pattern of concomitant cardiovascular diseases (CVDs) and to estimate ..." | ||
| Vol 5, No 2 (2009) | DOCTOR INERTNESS AS A FACTOR DISTURBING EFFECTIVE TREATMENT OF CARDIOVASCULAR DISEASES | Abstract similar documents |
| E. V. Minakov, R. A. Khokhlov, G. I. Furmenko, N. M. Akhmedzhanov | ||
| "... which treat and follow-up patients with cardiovascular diseases (CVD). Material and methods ..." | ||
| Vol 18, No 3 (2022) | Aromatic Amino Acids: Phenylalanine and Tyrosine in Patients with Hypertension and Coronary Artery Disease | Abstract similar documents |
| A. V. Krivova, M. V. Kozhevnikova, E. O. Korobkova, V. Yu. Zektser, E. A. Zheleznykh, А. A. Ageev, N. E. Moskaleva, A. V. Kukharenko, S. A. Appolonova, Yu. N. Belenkov | ||
| "... with cardiovascular diseases (CVD): hypertension and coronary artery disease (CАD) in comparison with healthy study ..." | ||
| Vol 20, No 5 (2024) | Impact of non-high-density lipoprotein cholesterol in mortality and cardiovascular events among middle-aged Russian men: 40 years ago and now | Abstract PDF (Eng) similar documents |
| S. A. Shalnova, A. E Imaeva, Yu. A Balanova, V. A Kutsenko, A. V Kapustina, V. A Metelskaya, N. A Imaeva, B. M Nazarov, O. E Ivlev, E. B Yarovaya, O. M Drapkina | ||
| "... cardiovascular disease (CVD) who did not receive lipid-lowering therapy, participants of two independent ..." | ||
| Vol 17, No 6 (2021) | Prehospital Period in Patients with COVID-19: Cardiovascular Comorbidity and Pharmacotherapy During the First Epidemic Wave (Hospital Registry Data) | Abstract similar documents |
| S. Yu. Martsevich, M. M. Lukyanov, M. M. Pulin, N. P. Kutishenko, E. Yu. Andreenko, V. P. Voronina, V. A. Dindikova, N. A. Dmitrieva, A. V. Zagrebelnyy, O. V. Lerman, A. N. Makoveeva, E. Yu. Okshina, A. A. Smirnov, E. V. Kudryashov, I. V. Budaeva, E. S. Nikoshnova, O. E. Karpov, O. M. Drapkina | ||
| "... of prehospital pharmacotherapy of concomitant cardiovascular diseases (CVD). Material and methods. Patients were ..." | ||
| Vol 10, No 2 (2014) | PREVALENCE RATE OF PSYCHOGENIC RISK FACTORS AMONG PATIENTS WITH ARTERIAL HYPERTENSION OF VARIOUS DEGREES ACCORDING TO CRITERIA OF EVIDENCE-BASED MEDICINE | Abstract similar documents |
| B. B. Fishman, I. N. Kochanov, A. I. Horoshevskaja, M. A. Bobyr, D. A. Shamiladze, L. A. Fomenko, V. V. Kostirkina, Yu. O. Yevstyukhina | ||
| "... by logistical regress model using disagreement criterion (odds ratio). Results. HT prevalence rate was 52 ..." | ||
| Vol 12, No 6 (2016) | CONCOMITANT CARDIOVASCULAR DISEASES AND ANTIHYPERTENSIVE TREATMENT IN OUTPATIENT PRACTICE (BY THE RECVASA REGISTRY DATA) | Abstract similar documents |
| M. Loukianov | ||
| "... Aim. To study a pattern of concomitant cardiovascular diseases (CVDs) and to estimate ..." | ||
| Vol 12, No 5 (2016) | The Value of Subclinical Carotid Atherosclerosis for Primary Prevention of Cardiovascular Diseases. Review of the Main International Studies | Abstract similar documents |
| E. K. Butina, E. V. Bochkareva | ||
| "... Measures for the prevention of cardiovascular diseases (CVD) are more effective ..." | ||
| Vol 14, No 4 (2018) | Role of Gut Microbiota in the Pathogenesis of Cardiovascular Diseases and Metabolic Syndrome | Abstract similar documents |
| O. M. Drapkina, O. E. Shirobokikh | ||
| "... The role of gut microbiota in the pathogenesis of cardiovascular diseases (CVD) and metabolic ..." | ||
| Vol 16, No 5 (2020) | Possible Approaches to Primary Prevention of Cardiovascular Diseases | Abstract similar documents |
| V. N. Larina, D. S. Mkrtychev, V. A. Kuznetsova, A. A. Tyazhelnikov | ||
| "... with the development of cardiovascular diseases (CVD), allowed the experts of the American Heart Association to develop ..." | ||
| Vol 15, No 2 (2019) | Mammographic Screening as a Tool for Cardiovascular Risk Assessing. Part 1. Breast Arterial Calcification: Pathomorphology, Prevalence and Risk Factors | Abstract similar documents |
| E. V. Bochkareva, I. V. Kim, E. K. Butina, I. D. Stulin, S. A. Trukhanov, B. A. Rudenko, S. A. Boytsov, O. M. Drapkina | ||
| "... with cardiovascular diseases (CVD). This allows it to be considered as a new marker of cardiovascular risk in women ..." | ||
| Vol 15, No 3 (2019) | Mammographic Screening as a Tool for Cardiovascular Risk Assessing. Part 2. Association of Breast Arterial Calcification and Cardiovascular Diseases | Abstract similar documents |
| E. V. Bochkareva, I. V. Kim, E. K. Butina, I. D. Stulin, S. A. Trukhanov, B. A. Rudenko, S. A. Boytsov, O. M. Drapkina | ||
| "... with the prevalence and mortality from cardiovascular diseases (CVD). The presence of BAC on mammograms is associated ..." | ||
| Vol 13, No 4 (2017) | OCCURRENCE OF THE METABOLIC SYNDROME AND ITS EFFECT ON CARDIOVASCULAR RISK IN PATIENTS WITH GOUT | Abstract similar documents |
| I. I. Polskaya, I. M. Marusenko, T. I. Kulagina, N. N. Vezikova | ||
| "... (CVD) in patients with gout depending on the presence of MS. Material and methods. 56 patients (aged ..." | ||
| Vol 18, No 6 (2022) | Predictors of Long-Term Outcomes after Surgical Myocardial Revascularization | Abstract similar documents |
| V. S. Kaveshnikov, M. A. Kuzmichkina, V. N. Serebryakova | ||
| "... High mortality from cardiovascular diseases (CVD) requires improved approaches to the treatment ..." | ||
| Vol 12, No 6 (2016) | THE STUDY "REGISTER OF PATIENTS AFTER ACUTE STROKE (REGION)." Part 1. Hospital Prospective Register of Patients after Acute Stroke (According to the Results of the Pilot Phase of the Study) | Abstract similar documents |
| S. A. Boytsov, S. Yu. Martsevich, N. P. Kutishenko, M. M. Loukianov, A. E. Mitichkin, R. V. Viskov, L. V. Stakhovskaya, N. A. Shamalov, G. P. Arutyunov, I. V. Kokareva, N. E. Parsadanyan, M. I. Chernyshova, A. V. Zagrebelnyy, N. A. Dmitrieva, A. V. Akimova, G. I. Nikitina, O. V. Lerman, V. P. Voronina, E. N. Belova, E. N. Kudryashov, A. D. Deev | ||
| "... of the closest outpatient clinics). Presence of cardiovascular diseases (CVD) and their risk factors (RF ..." | ||
| Vol 19, No 3 (2023) | Plasma branched-chain amino acid concentrations in individuals without cardiovascular diseases versus patients diagnosed with hypertension and coronary artery disease | Abstract similar documents |
| M. V. Kozhevnikova, E. O. Korobkova, A. V. Krivova, A. V. Kukharenko, N. E. Moskaleva, K. M. Shestakova, N. V. Mesonzhnik, A. A. Ageev, A. A. Boldin, A. Brito, S. А. Appolonova, E. V. Privalova, Y. N. Belenkov | ||
| "... BCAAs (valine, leucine and isoleucine) in individuals without cardiovascular diseases (CVDs) (nonCVD ..." | ||
| Vol 5, No 3 (2009) | CARDIOVASCULAR DISEASES TREATMENT IN PATIENTS WITH TYPE 2 DIABETES MELLITUS IN CURRENT CLINICAL PRACTICE | Abstract PDF (Eng) similar documents |
| I. E. Sapozhnikova, E. I. Tarlovskaya, E. N. Anufrieva | ||
| "... Aim. To evaluate cardiovascular diseases (CVD) treatment in patients with type 2 diabetes mellitus ..." | ||
| Vol 16, No 3 (2020) | Angiogenesis in Patients with Chronic Heart Failure: Focus on Endothelial Vascular Growth Factor, Pentraxin-3 and Transforming Growth Factor Beta | Abstract similar documents |
| R. N. Shepel, O. M. Drapkina | ||
| "... cardiovascular (CVD) and metabolic diseases. Although the current treatment strategy has improved survival ..." | ||
| Vol 19, No 5 (2023) | Relationship between parameters of subclinical atherosclerosis and osteoporosis and their prognostic significance: data from the prospective studies | Abstract similar documents |
| I. A. Skripnikova, M. A. Kolchina, O. V. Kosmatova, T. T. Tsoriev, O. Yu. Isaykina, O. M. Drapkina | ||
| "... We analyzed modern publications on the relationship between cardiovascular diseases (CVDs ..." | ||
| Vol 18, No 1 (2022) | Cardiovascular Effects of Metformin | Abstract similar documents |
| B. T. Kurmanbekova, A. M. Noruizbaeva | ||
| "... , progression and mortality from cardiovascular diseases (CVD). The world communities are faced ..." | ||
| Vol 14, No 5 (2018) | Economic losses due to low coverage of lipid-lowering therapy in patients with cardiovascular diseases in the Russian Federation | Abstract similar documents |
| Yu. A. Balanova, A. V. Kontsevaya, A. E. Imaeva, O. I. Karpov, M. B. Khudyakov | ||
| "... ) in patients with cardiovascular diseases (CVD) and hypercholesterolemia (HCS) in the Russian population ..." | ||
| Vol 14, No 3 (2018) | ECONOMIC BURDEN OF HYPERCHOLESTEROLEMIA IN THE RUSSIAN FEDERATION | Abstract similar documents |
| A. V. Kontsevaya, Yu. A. Balanova, A. E. Imaeva, M. B. Khudyakov, O. I. Karpov, O. M. Drapkina | ||
| "... on local published studies. Local statistical data (2016) on cardio-vascular diseases (CVDs), including ..." | ||
| Vol 7, No 6 (2011) | DETERMINANTS OF PREVENTIVE BEHAVIOR REGARDING CARDIOVASCULAR DISEASES AND RISK FACTORS IN PATIENTS WITH ESSENTIAL HYPERTENSION AND CHRONIC ISCHEMIC HEART DISEASE | Abstract similar documents |
| D. Yu. Platonov, T. A. Kostjuk, A. I. Brandt, O. V. Tsygankova | ||
| "... logistic regression. Results. Awareness of the cardiovascular diseases (CVD) and its prevention (odds ratio ..." | ||
| Vol 8, No 5 (2012) | HIGH HEART RATE AS A POTENTIAL RISK FACTOR FOR DEVELOPMENT OF CARDIOVASCULAR DISEASES IN WOMEN WITH RHEUMATOID ARTHRITIS | Abstract similar documents |
| D. S. Novikova, T. V. Popkova, A. N. Gerasimov, A. V. Volkov, E. L. Nasonov | ||
| "... diseases (TRF for CVD), subclinical structural and functional changes in the heart and vessels, as well ..." | ||
| Vol 14, No 5 (2018) | Effect of Previous Cardiovascular Diseases on Long-Term Outcomes of Acute Myocardial Infarction: Data of the Outpatient Registry "PROFILE-IM” | Abstract similar documents |
| N. P. Kutishenko, D. P. Sichinava, E. P. Kalaydzhyan, V. A. Evdakov, E. A. Kasparova, S. Yu. Martsevich | ||
| "... (AMI), to assess the influence of factors in medical history, especially cardiovascular diseases (CVD ..." | ||
| Vol 16, No 4 (2020) | From Low-Dose Fixed Combinations for Arterial Hypertension Treatment to Multi-Target Therapy of Cardiovascular Diseases | Abstract similar documents |
| P. A. Lebedev, A. A. Garanin | ||
| "... as the most effective approach to the fight against cardiovascular diseases (CVD). The priority of domestic ..." | ||
| Vol 14, No 1 (2018) | ASSOCIATION OF RISK FACTORS FOR NON-COMMUNICABLE DISEASES WITH HEALTH CARE RESOURCES UTILIZATION AND TEMPORARY DISABILITY ACCORDING TO DATA OF POPULATION STUDY IN RUSSIAN FEDERATION | Abstract similar documents |
| E. I. Suvorova, S. A. Shalnova, A. V. Kontsevaya, A. D. Deev, A. V. Kapustina, Yu. A. Balanova | ||
| "... disability (TD) with the main risk factors (RF) for cardiovascular diseases (CVD) in working age population ..." | ||
| Vol 8, No 6 (2012) | THE RELATIONSHIP OF CARDIOVASCULAR RISK FACTORS AND ARTERIAL WALL STIFFNESS IN WOMEN WITH A HIGH ACTIVITY OF RHEUMATOID ARTHRITIS | Abstract similar documents |
| D. S. Novikova, T. V. Popkova, A. N. Gerasimov, A. V. Volkov, E. L. Nasonov | ||
| "... ) of cardiovascular disease (CVD), duplex scanning of the common carotid arteries, transthoracic echocardiography ..." | ||
| Vol 1, No 1 (2005) | TOBACCO DEPENDENCE TREATMENT WITH NICOTINE REPLACEMENT THERAPY AS ONE OF THE METHODS FOR CARDIOVASCULAR DISEASE RISK REDUCTION | Abstract similar documents |
| O. V. Vikhireva, S. A. Shalnova, A. D. Deev | ||
| "... to quit smoking. To assess expected reduction of cardiovascular disease (CVD) and total mortality relative ..." | ||
| Vol 19, No 1 (2023) | Microbiota and Cardiovascular Diseases: Mechanisms of Influence and Correction Possibilities | Abstract similar documents |
| A. V. Gorbenko, Y. P. Skirdenko, K. A. Andreev, M. M. Fedorin, N. A. Nikolaev, M. A. Livzan | ||
| "... types. The link between the gut microbiota and cardiovascular disease (CVD) is being actively ..." | ||
| Vol 14, No 6 (2018) | Cardiovascular Diseases and Drug Treatment in Patients with the History of Cerebral Stroke: Data of the Outpatient Registry REGION | Abstract PDF (Eng) similar documents |
| M. M. Loukianov, S. S. Yakushin, S. Yu. Martsevich, O. M. Drapkina, A. N. Vorobyev, A. V. Zagrebelnyy, A. N. Kozminsky, K. A. Moseichuk, K. G. Pereverzeva, E. A. Pravkina, E. Yu. Okshina, E. V. Kudryashov, E. N. Belova, V. G. Klyashtorny, S. A. Boytsov | ||
| "... diseases (CVD), compliance with the clinical recommendations of the prescribed and received drug therapy ..." | ||
| Vol 16, No 3 (2020) | Economic Burden of Hypertension in the Russian Federation | Abstract similar documents |
| Yu. A. Balanova, A. V. Kontsevaya, A. O. Myrzamatova, D. K. Mukaneeva, M. B. Khudyakov, O. M. Drapkina | ||
| "... of hypertension for cardiovascular diseases (CVD) (including stroke and coronary heart disease), chronic ..." | ||
| Vol 20, No 2 (2024) | The relationship of arterial hypertension, elevated low-density lipoprotein cholesterol and their combination with the occurrence of new cases of cardiovascular diseases in men and women of working age | Abstract similar documents |
| S. A. Shalnova, E. B. Yarovaya, V. A. Metelskaya, E. M. Filichkina, A. V. Kapustina, V. A. Kutsenko, Yu. A. Balanova, A. E. Imaeva, G. A. Muromtseva, S. E. Evstifeeva, S. A. Maksimov, N. V. Kulakova, O. N. Kalachikova, T. M. Chernykh, O. A. Belova, G. V. Artamonova, Yu. I. Grinshtein, R. A. Libis, O. P Rotar, I. A. Trubacheva, A. Yu. Efanov, S. S. Yakushin, A. N. Redko, I. A. Viktorova, N. N. Prishchepa, A. O. Konradi, S. A. Boytsov, E. V Shlyakhto, O. M. Drapkina | ||
| "... for gender, age and region. There was a significantly higher risk of new cases of nonfatal CVD in individuals ..." | ||
| Vol 16, No 1 (2020) | Alirocumab Administration Experience to Achieve Low Density Lipoprotein Cholesterol Target Levels in Secondary Prevention of Cardiovascular Disease | Abstract similar documents |
| A. E. Nikitin, E. E. Averin, D. E. Rozhkov, A. V. Sozykin, G. A. Procenko | ||
| "... , alirocumab, on lipid levels in patients who receive secondary prevention of cardiovascular diseases (CVD ..." | ||
| Vol 14, No 5 (2018) | Chronic Heart Failure in Rheumatoid Arthritis Patients (Part I): Prevalence, Etiology and Pathogenesis | Abstract similar documents |
| D. S. Novikova, I. G. Kirillova, H. V. Udachkina, T. V. Popkova | ||
| "... (CVD). Inflammation plays a leading role in the development of CHF through various mechanisms including ..." | ||
| Vol 14, No 5 (2018) | Drug Therapy Structure and Clinical Characteristics of Patients with Atrial Fibrillation According to Data of REKUR-AF Study | Abstract similar documents |
| I. L. Polshakova, S. V. Povetkin | ||
| "... data, the type and duration of AF, cardiovascular diseases (CVD), concomitant noncardiac pathology ..." | ||
| Vol 18, No 3 (2022) | Association of Heart Rate Variability with the Psychosocial Stress Level in Men 41-44 Years Old Living in Moscow | Abstract similar documents |
| O. M. Drapkina, V. B. Rozanov, A. V. Kontsevaya, O. Yu. Isaykina, G. A. Muromtseva, M. B. Kotova, E. S. Akarachkova | ||
| "... factors (RF) for cardiovascular diseases (CVD) was carried out in accordance with generally accepted ..." | ||
| Vol 16, No 6 (2020) | Population-based Cardiovascular Disease Prevention Measures Aimed at Reducing Salt Intake: Analysis of International Strategies and Prospects for Implementation in the Russian Federation | Abstract similar documents |
| Yu. A. Balanova, A. V. Kontsevaya, N. S. Karamnova, D. K. Mukaneeva, O. M. Drapkina | ||
| "... High salt intake is an important risk factor for cardiovascular diseases (CVD), closely related ..." | ||
| Vol 5, No 2 (2009) | ASSESSMENT OF AMLODIPINE ANTIHYPERTENSIVE EFFECT HOMOGENEITY IN CONTROLLED TRIAL | Abstract similar documents |
| V. M. Gorbunov, M. I. Smirnova, A. D. Deev | ||
| "... was 11,2±1,8/7,6±1,2 mm Hg in amlodipine therapy and 10,0±1,8/7,1±1,2 in spirapril therapy (p<0,0001 ..." | ||
| Vol 17, No 2 (2021) | Current Guidelines for the Treatment of Arterial Hypertension in Patients with Diabetes Mellitus and Chronic Kidney Disease | Abstract similar documents |
| T. Yu. Demidova, O. A. Kislyak | ||
| "... diseases (CVD), but also the prevention and treatment of chronic kidney disease (CKD). The fact ..." | ||
| Vol 14, No 5 (2018) | Metabolic Syndrome: Development of the Issue, Main Diagnostic Criteria | Abstract similar documents |
| Yu. N. Belenkov, E. V. Privalova, V. Y. Kaplunova, V. Y. Zektser, N. N. Vinogradova, I. S. Ilgisonis, G. A. Shakaryants, M. V. Kozhevnikova, A. S. Lishuta | ||
| "... более тяжелое их течение. За последние несколько десятилетий формулировка критериев метаболического ..." | ||
| Vol 12, No 6 (2016) | EFFICIENCY OF INFLUENZA VACCINATION IN PATIENTS WITH CIRCULATORY SYSTEM DISEASES UNDER DISPENSARY OBSERVATION IN OUTPATIENT CLINICS: PROSPECTIVE FOLLOW-UP MONITORING DATA | Abstract similar documents |
| S. A. Boytsov, M. M. Loukianov, E. V. Platonova, V. M. Gorbunov, S. V. Romanchuk, O. A. Nazarova, O. A. Belova, E. A. Kravtsova, P. Ya. Dovgalevsky, N. V. Furman, A. A. Mironova, P. V. Dolotovskaya, A. V. Nekrasov, N. G. Puchkova, M. A. Abramova, E. N. Belova, V. G. Klyashtorny, A. D. Deev | ||
| "... -vaccinated group (28 and 442; р<0.0001). The vaccinated group had fewer CSD worsening cases per patient (p=0 ..." | ||
| Vol 13, No 1 (2017) | THE STUDY "REGISTER OF PATIENTS AFTER ACUTE STROKE (REGION)". PART 2. OUTPATIENT PROSPECTIVE REGISTER OF PATIENTS AFTER ACUTE STROKE (ACCORDING TO THE RESULTS OF THE PILOT PHASE OF THE STUDY) | Abstract PDF (Eng) similar documents |
| S. А. Boytsov, M. M. Loukianov, S. S. Yakushin, S. Yu. Martsevich, L. V. Stakhovskaya, A. N. Vorobyev, A. V. Zagrebelnyy, N. P. Kutishenko, A. N. Kozminsky, K. A. Moseichuk, K. G. Pereverzeva, E. A. Pravkina, E. N. Belova, E. V. Kudryashov, A. D. Deev | ||
| "... , concomitant cardiovascular diseases (CVD) and noncardiac diseases were analyzed. We estimated accordance ..." | ||
| Vol 13, No 4 (2017) | CLINICAL PRACTICE OF BETA-BLOCKERS USAGE IN PATIENTS WITH CARDIOVASCULAR AND CHRONIC RESPIRATORY DISEASES. DATA OF OUTPATIENT REGISTRIES PROFILE AND RECVASA | Abstract similar documents |
| S. Yu. Martsevich, N. A. Zakharova, N. P. Kutishenko, A. V. Zagrebelnyy, Yu. V. Lukina, M. M. Loukianov, A. N. Vorobyev, A. N. Kozminsky | ||
| "... diseases (CVD) in the presence of limitations (chronic obstructive pulmonary disease – COPD ..." | ||
| Vol 17, No 6 (2021) | Cardiovascular Diseases and Non-Alcoholic Fatty Liver Disease: Relationship and Pathogenetic Aspects of Pharmacotherapy | Abstract similar documents |
| A. V. Nelidova, M. A. Livzan, N. A. Nikolaev, T. S. Krolevets | ||
| "... (CVD), but also increases the risk of overall mortality by 69% due to mortality from ..." | ||
| Vol 20, No 5 (2024) | Lipoprotein(a), atherosclerosis and cardiovascular risk | Abstract similar documents |
| E. A. Polyakova, Iu. S. Khalimov, E. A. Bazhenova, T. M. Bakher | ||
| "... заболеваний (ССЗ). Атерогенность Лп(a) выше, чем липопротеинов низкой плотности в 6 раз и может быть причиной ..." | ||
| Vol 18, No 4 (2022) | Non-High Density Lipoprotein Cholesterol: A Modern Benchmark for Assessing Lipid Metabolism Disorders | Abstract PDF (Eng) similar documents |
| S. A. Shalnova, V. A. Metelskaya, V. A. Kutsenko, E. B. Yarovaya, A. V. Kapustina, G. A. Muromtseva, G. E. Svinin, Yu. A. Balanova, A. E. Imaeva, S. E. Evstifeeva, V. G. Vilkov, O. L. Barbarash, O. A. Belova, Yu. I. Grinshtein, A. Yu. Efanov, O. N. Kalachikova, N. V. Kulakova, O. P. Rotar, I. A. Trubacheva, D. V. Duplyakov, R. A. Libis, I. A. Viktorova, A. N. Redko, S. S. Yakushin, S. A. Boytsov, E. V. Shlyakhto, O. M. Drapkina | ||
| "... of cardiovascular diseases [CVD]". The analysis of nonlinear associations was performed using the generalized ..." | ||
| Vol 17, No 5 (2021) | Social Network-Based Digital Stroke Prevention: Opportunities, Results and Prospects | Abstract PDF (Eng) similar documents |
| A. E. Demkina, M. V. Bezzubtseva, M. N. Ryabinina, Ya. A. Kotlyar, O. L. Keln, А. V. Sarapulova, R. R. Zhetishev, V. S. Kuvaev, M. Y. Maksimova, N. V. Pogosova, I. V. Zhetisheva | ||
| "... the stroke risk factors for diabetes mellitus, other cardiovascular diseases (CVD), obesity, and alcohol use ..." | ||
| Vol 20, No 6 (2024) | Dehydroepiandrosterone and cognitive impairment and impact in cardiovascular mortality among men and women 55 years and older | Abstract similar documents |
| S. A. Shalnova, N. A. Imaeva, A. E. Imaeva, V. A. Kutsenko, Yu. A. Balanova, A. V. Kapustina, O. M. Drapkina | ||
| "... from CVD were registered. Results. A total of 1876 participants aged 55 years and older (48% men ..." | ||
| Vol 16, No 5 (2020) | Pharmacoeconomic Analysis of Therapy with Generic Statin Drugs in Patients with High and Very High Cardiovascular Risk (According to the Study PRIORITY) | Abstract similar documents |
| S. Yu. Martsevich, Yu. V. Lukina, N. P. Kutishenko | ||
| "... level. Results. At the first stage of the pharmacoeconomic analysis, the criterion ..." | ||
| Vol 17, No 6 (2021) | Hyperuricemia: Features of the Diet | Abstract similar documents |
| O. B. Shvabskaia, O. V. Izmailova, N. S. Karamnova, O. M. Drapkina | ||
| "... The association of hyperuricemia (HU) with cardiovascular disease (CVD), diabetes, metabolic ..." | ||
| Vol 18, No 1 (2022) | Polymorbidity and Polypragmasia in High and Very High Cardiovascular Risk Patients | Abstract similar documents |
| N. V. Izmozherova, A. A. Popov, A. A. Kuryndina, E. I. Gavrilova, M. A. Shambatov, V. M. Bakhtin | ||
| "... . Определена частота полипрагмазии с помощью критериев STOPP/START и критериев Бирса 2019 г., проведен анализ ..." | ||
| Vol 15, No 6 (2019) | Outpatient Registry REGION: Prospective Follow-up Data and Outcomes in Patients After Acute Cerebrovascular Accident | Abstract similar documents |
| M. M. Loukianov, S. S. Yakushin, S. Yu. Martsevich, A. N. Vorobyev, K. G. Pereverzeva, E. Yu. Okshina, A. V. Zagrebelnyy, V. G. Klyashtorny, E. V. Kudryashov, S. A. Boytsov, O. M. Drapkina | ||
| "... myocardial infarction and ACVA), hospitalizations due to CV diseases (CVD) were evaluated during 37 (17 ..." | ||
| Vol 6, No 5 (2010) | THE INFECTIVE ENDOCARDITIS (PREVENTION, DIAGNOSIS CRITERIA AND TREATMENT): KEY POINTS 2010 | Abstract similar documents |
| A. A. Demin | ||
| Vol 18, No 2 (2022) | Sequelae of COVID-19 at long-term follow-up after hospitalization | Abstract PDF (Eng) similar documents |
| N. V. Pogosova, F. N. Paleev, A. K. Ausheva, D. T. Kuchiev, S. A. Gaman, T. N. Veselova, M. B. Belkind, O. Yu. Sokolova, R. A. Zhetisheva, S. K. Ternovoy, S. A. Boytsov | ||
| "... cardiovascular diseases (CVD). A total of 213 patients aged 19 to 94 years old (mean age 56.8±12.5, median 57 ..." | ||
| Vol 10, No 2 (2014) | STUDY OF URSODEOXYCHOLIC ACID INFLUENCE ON EFFICACY AND SAFETY OF STATIN THERAPY IN PATIENTS WITH DISEASES OF THE LIVER, GALL BLADDER AND/OR BILIARY TRACT (THE RAKURS STUDY) | Abstract similar documents |
| S. Yu. Martsevich, N. P. Kutishenko, L. Yu. Drozdova, O. V. Lerman, V. A. Nevzorova, I. I. Reznik, G. V. Shavkuta, D. A. Yahontov | ||
| "... in patients with cardiovascular diseases (CVD) and high risk of cardiovascular events (CVE) with indications ..." | ||
| Vol 14, No 5 (2018) | Dynamics of Carotid Intima-Media Thickness, Parameters of Arterial Stiffness and Ambulatory Blood Pressure Monitoring during Therapy with Inhibitor of Tumor Necrosis Factor-Alpha in Patients with Early Psoriatic Arthritis | Abstract similar documents |
| E. I. Markelova, D. S. Novikova, T. V. Korotaeva, E. Yu. Loginova | ||
| "... (CVD). Anti-tumor necrosis factor (TNF) therapy is an effective in PsA but its cardiovascular effects ..." | ||
| Vol 18, No 4 (2022) | Detection and Treatment of Hyperuricemia in Clinical Practice (According to the PROFILE Outpatient Registry) | Abstract similar documents |
| N. P. Kutishenko, S. Yu. Martsevich, A. V. Zagrebelnyy, Yu. V. Lukina, V. P. Voronina, N. A. Dmitrieva, O. V. Lerman, S. N. Tolpygina, S. V. Blagodatskikh, I. V. Budaeva, E. S. Nekoshnova, O. M. Drapkina | ||
| "... . Conclusion: in real clinical practice, only 29.1% of patients with AH and 20-25% of patients with other CVDs ..." | ||
| Vol 9, No 6 (2013) | FEATURES OF SEASONAL CARDIOVASCULAR MORTALITY IN WINTER IN RUSSIAN REGIONS WITH DIFFERENT CLIMATIC AND GEOGRAPHICAL CHARACTERISTICS | Abstract similar documents |
| S. A. Boytsov, M. M. Lukyanov, A. V. Kontsevaya, A. D. Deev, Yu. A. Balanova, A. V. Kapustina, V. G. Klyashtorny, M. B. Hudyakov | ||
| "... -November (p<0.0001) were found. Cardiovascular mortality decreased from 2007 to 2012 by 32.4% and by 32 ..." | ||
| Vol 7, No 3 (2011) | POTASSIUM INTAKE, STROKE, AND CARDIOVASCULAR DISEASE: A META-ANALYSIS OF PROSPECTIVE STUDIES | similar documents |
| L. D'Elia, G. Barba, F. P. Cappuccio, P. Strazzullo | ||
| "... -сосудистых заболеваний (ССЗ). Введение. Cвязь между привычным потреблением калия и частотой сосудистых ..." | ||
| Vol 10, No 1 (2014) | ASSOCIATION BETWEEN HEART RATE VARIABILITY AND COMPONENTS OF THE METABOLIC SYNDROME IN WOMEN WITH RHEUMATOID ARTHRITIS | Abstract similar documents |
| D. S. Novikova, T. V. Popkova, A. N. Gerasimov, A. V. Volkov, E. L. Nasonov | ||
| "... тяжести РА оценивалось наличие традиционных факторов риска (ТФР) сердечно-сосудистых заболеваний (ССЗ ..." | ||
| Vol 5, No 1 (2009) | NEW DEFINITIONS OF MYOCARDIAL INFARCTIONS (COMMENTS ON “UNIVERSAL DEFINITIONS OF MYOCARDIAL INFARCTION” PUBLISHED IN №5, 2008) | Abstract similar documents |
| A. V. Shpector, E. Yu. Vasilyeva | ||
| "... Новые диагностические критерии инфаркта миокарда (комментарии к «Универсальному определению ..." | ||
| Vol 20, No 4 (2024) | Should a physician use the Beers criteria when prescribing direct oral anticoagulants to elderly patients? | Abstract similar documents |
| N. M. Vorobyeva, I. P. Malaya, V. D. Zakiev, O. N. Tkacheva | ||
| "... Критерии Бирса — инструмент оптимизации фармакотерапии у пожилых пациентов, содержащий информацию ..." | ||
| Vol 20, No 4 (2024) | Mural infectious endocarditis in a patient with tetralogy of Fallot: a clinical case | Abstract similar documents |
| I. E. Kotlyar, A. E. Filchkova, N. V. Enenkov, A. S. Sidashova, D. O. Kondratyev, N. V. Dobrynina, K. I. Vasyushkina, T. A. Gorokhova | ||
| "... , based on the identification of 1 major Duke criterion (imaging criterion — the presence of parietal ..." | ||
| Vol 16, No 2 (2020) | Glomerular Filtration Rate, its Association with Risk Factors and Cardiovascular Diseases. The Results of the ESSE-RF-2 Study | Abstract similar documents |
| S. A. Shalnova, S. A. Maksimov, Yu. A. Balanova, S. E. Evstifeeva, A. E. Imaeva, A. V. Kapustina, G. A. Muromtseva, V. I. Tarasov, I. A. Viktorova, A. N. Redko, N. N. Prishchepa, S. S. Yakushin, O. M. Drapkina | ||
| "... (CVD) and cardiovascular risk factors among the population of four Russian regions included in the ESSE ..." | ||
| Vol 15, No 1 (2019) | The Trends of Cardiovascular and Cancer Mortality in Russian Men and Women from 2000 to 2016 years | Abstract similar documents |
| S. A. Shalnova, O. M. Drapkina | ||
| "... Aim. To compare trends from CVD and cancer mortality in the Russian Federation from 2000 to 2016 ..." | ||
| Vol 6, No 3 (2010) | RHEUMATIC FEVER AS NONVANISHING DISEASE: A PROBLEM STATE AND CLINICAL CASES | Abstract similar documents |
| N. A. Shostak, A. A. Klimenko, I. V. Novikov, D. J. Andrijashkina, M. S. Churilova | ||
| Vol 15, No 6 (2019) | Characteristics of Patients with Reproducible Masked Hypertension and its Diagnosis Approach | Abstract similar documents |
| М. I. Smirnova, V. M. Gorbunov, Ya. N. Koshelyaevskaya, A. D. Deev, D. A. Volkov, N. V. Furman, P. V. Dolotovskaya | ||
| "... ). In multivariate analysis, reproducible MH was associated with body mass index (β2.097; p<0.0001), office diastolic ..." | ||
| Vol 6, No 4 (2010) | RUSSIAN EXPERTS’ CONSENSUS ON METABOLIC SYNDROME PROBLEM IN THE RUSSIAN FEDERATION: DEFENITION, DIAGNOSIS CRITERIA, PRIMARY PREVENTION AND TREATMENT | Abstract similar documents |
| N. M. Achmegdanov, S. A. Butrusova, I. I. Dedov, L. A. Zvenigorodskaya, O. A. Kislyak, O. A. Koshelskaya, I. V. Kuznecova, V. V. Kuharchuk, A. Yu. Litvin, I. V. Medvedeva, A. M. Mkrtumyan, V. B. Mychka, D. V. Nebieridze, S. V. Nedogoda, R. G. Oganov, M. Yu. Ogarkov, N. B. Perepech, V. I. Podzolkov, V. P. Smetnik, A. V. Susekov, V. N. Titov, T. V. Tyurina, A. N. Fursov, V. N. Hirmanov, I. E. Chazova, I. I. Chukaeva, M. V. Shestakova, A. T. Shubina | ||
| Vol 21, No 1 (2025) | The Beers criteria role in predicting bleeding during the use of direct oral anticoagulants in patients with atrial fibrillation over 80 years of age | similar documents |
| M. S. Cherniaeva, M. A. Rozhkova, E. S. Ilyina, E. A. Moiseeva, E. A. Gorelov, L. A. Egorova, O. M. Maslennikova, N. V. Lomakin, D. A. Sychev | ||
| "... ) согласно критериям Бирса и оценить их роль в прогнозировании клинически значимого небольшого кровотечения ..." | ||
| Vol 14, No 5 (2018) | Safety and Effectiveness of Electrical and Pharmacological Cardioversion in Persistent Atrial Fibrillation. Part I: Study Rationale, Design and Assessment of Effectiveness | Abstract similar documents |
| N. Yu. Mironov, V. V. Vlodzyanovskiy, Yu. A. Yuricheva, S. F. Sokolov, S. P. Golitsyn, L. V. Rosenstraukh, E. I. Chazov | ||
| "... interval (CI) for primary effectiveness criterion was [-0.1 – 0.16]. AF recurred in 1 patient after ..." | ||
| Vol 13, No 5 (2017) | RATIONAL PHARMACOTHERAPY IN CARDIOLOGY: FROM ROUTINE CONTROL TO EFFECTIVE MANAGEMENT | Abstract similar documents |
| N. А. Nikolayev, Y. P. Skirdenko, S. S. Bunova, A. V. Ershov | ||
| "... therapy demonstrated a statistically significant advantage over conventional therapy by the criterion ..." | ||
| Vol 18, No 3 (2022) | Dynamics of 6-Minute Walk Distance as a Predictor of Efficiency Specific Pulmonary Vasodilators | Abstract similar documents |
| A. A. Shmalts | ||
| "... significantly improved the prognosis of patients. An accessible and reproducible criterion of exercise tolerance ..." | ||
| Vol 16, No 4 (2020) | Epicardial Adipose Tissue as a New Target of Therapeutic Interventions | Abstract similar documents |
| M. A. Druzhilov, T. Y. Kuznetsova | ||
| "... target and a criterion for their effectiveness. Its unique characteristics suggest the advisability ..." | ||
| 1 - 100 of 322 Items | 1 2 3 4 > >> | |
Search tips:
- Search terms are case-insensitive
- Common words are ignored
- By default articles containing any term in the query are returned (i.e., OR is implied)
- Make sure that a word exists in an article by prefixing it with +; e.g., +journal +access scholarly academic
- Combine multiple words with AND to find articles containing all terms; e.g., education AND research
- Exclude a word by prefixing it with - or NOT; e.g., online -politics or online NOT politics
- Search for an exact phrase by putting it in quotes; e.g., "open access publishing". Hint: Quoting Chinese or Japanese words will help you to find exact word matches in mixed-language fields, e.g. "中国".
- Use parentheses to create more complex queries; e.g., archive ((journal AND conference) NOT theses)
.jpg)
